Video-on-Demand Library

Play

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

PSI Conference 2018: Model-Based Network Meta-Analysis (MBNMA) in pharmacometrics

05 June 2018

Model-based meta-analysis (MBMA) is a technique increasingly used in drug development for synthesising results from multiple studies, allowing pooling of information on non-linear dose-response and time-course characteristics. Such analyses can substantially increase the power to detect small but potentially clinically significant effects and can be used to support decision-making and inform future trial designs. We have extended this technique to multiple treatment-comparisons by incorporating methods for network meta-analysis into MBMA models, using a Bayesian approach. Our model-based network meta-analysis (MBNMA) preserves randomisation by aggregating within-study relative effects, and allows for formal testing of consistency between direct and indirect evidence for dose-response and time-course models. We illustrate this approach using an example from time-course MBNMA and highlight the value of these techniques in both drug development and for reimbursement agencies.

Related Documents

Part of Collection(s)

Topic(s)

Upcoming Events

PSI Introduction to Industry Training (ITIT) Course - 2025/2026

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance

This will be a 45 minute webinar which will explain the topic presented in the published paper, ‘Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance’. There will be 15 minutes for a panel Q&A with some of the authors following the presentation.

PSI Webinar: Methodology and first results of the iRISE (improving Reproducibility In SciencE) consortium

This 1-hour webinar will be an opportunity to hear about the methodology and first results of the iRISE consortium. iRISE is working towards a better understanding of reproducibility and the interventions that work to improve it. At the end of the presentation there will also be the opportunity to ask questions.

One-day Event: Change Management for Moving to R/Open-Source

This one-day event focuses on the comprehensive management of transitioning to R/Open-Source, addressing the challenges and providing actionable insights. Attendees will participate in sessions covering essential topics such as training best practices, creating strategic plans, making the case to senior management, and managing both statistical and programming aspects of the transition.

Latest Jobs

Principal Statistician - Labcorp

This is an exciting, new opportunity for an experienced Statistician looking to take the next step in their career. Offered as a remote or hybrid position aligned with our site in Harrogate, North Yorkshire.